The exacerbating roles of CCAAT/enhancer-binding protein homologous protein (CHOP) in the development of bleomycin-induced pulmonary fibrosis and the preventive effects of tauroursodeoxycholic acid (TUDCA) against pulmonary fibrosis in mice

Yuta Tanaka, Yoichi Ishitsuka, Marina Hayasaka, Yusei Yamada, Keishi Miyata, Motoyoshi Endo, Yuki Kondo, Hiroshi Moriuchi, Mitsuru Irikura, Ken Ichiro Tanaka, Tohru Mizushima, Yuichi Oike, Tetsumi Irie

研究成果: Article

17 引用 (Scopus)

抄録

The purpose of this study was to evaluate the role of CCAAT/enhancer-binding protein homologous protein (CHOP), an important transcription factor that regulates the inflammatory reaction during the endoplasmic reticulum (ER) stress response, in the development of pulmonary fibrosis induced by bleomycin (BLM) in mice. An intratracheal injection of BLM transiently increased the expression of CHOP mRNA and protein in an early phase (days 1 and 3) in mice lungs. BLM-induced pulmonary fibrosis was significantly attenuated in Chop gene deficient (Chop KO) mice, compared with wild-type (WT) mice. Furthermore, the inflammatory reactions evaluated by protein concentration, the total number of leucocytes and neutrophils in the bronchoalveolar lavage fluid (BALF), the mRNA expression of interleukin 1b and caspase 11, and the apoptotic cell death were suppressed in Chop KO mice compared with those in WT mice. In addition, administration of tauroursodeoxycholic acid (TUDCA), a pharmacological agent that can inhibit CHOP expression, inhibited the BLM-induced pulmonary fibrosis and inflammation, and the increase in Chop mRNA expression in WT mice in a dose-dependent manner. These results suggest that the ER stress-induced transcription factor, CHOP, at least in part, plays an important role in the development of BLM-induced pulmonary fibrosis in mice, and that the inhibition of CHOP expression by a pharmacological agent, such as TUDCA, may be a promising strategy for the prevention of pulmonary fibrosis.

元の言語English
ページ(範囲)52-62
ページ数11
ジャーナルPharmacological Research
99
DOI
出版物ステータスPublished - 2015 6 11

Fingerprint

CCAAT-Enhancer-Binding Proteins
Pulmonary Fibrosis
Bleomycin
Proteins
Transcription Factor CHOP
Endoplasmic Reticulum Stress
Messenger RNA
Pharmacology
tauroursodeoxycholic acid
indium-bleomycin
Interleukins
Bronchoalveolar Lavage Fluid
Caspases
Leukocyte Count
Pneumonia
Neutrophils
Cell Death
Lung
Injections

ASJC Scopus subject areas

  • Pharmacology

これを引用

The exacerbating roles of CCAAT/enhancer-binding protein homologous protein (CHOP) in the development of bleomycin-induced pulmonary fibrosis and the preventive effects of tauroursodeoxycholic acid (TUDCA) against pulmonary fibrosis in mice. / Tanaka, Yuta; Ishitsuka, Yoichi; Hayasaka, Marina; Yamada, Yusei; Miyata, Keishi; Endo, Motoyoshi; Kondo, Yuki; Moriuchi, Hiroshi; Irikura, Mitsuru; Tanaka, Ken Ichiro; Mizushima, Tohru; Oike, Yuichi; Irie, Tetsumi.

:: Pharmacological Research, 巻 99, 11.06.2015, p. 52-62.

研究成果: Article

Tanaka, Yuta ; Ishitsuka, Yoichi ; Hayasaka, Marina ; Yamada, Yusei ; Miyata, Keishi ; Endo, Motoyoshi ; Kondo, Yuki ; Moriuchi, Hiroshi ; Irikura, Mitsuru ; Tanaka, Ken Ichiro ; Mizushima, Tohru ; Oike, Yuichi ; Irie, Tetsumi. / The exacerbating roles of CCAAT/enhancer-binding protein homologous protein (CHOP) in the development of bleomycin-induced pulmonary fibrosis and the preventive effects of tauroursodeoxycholic acid (TUDCA) against pulmonary fibrosis in mice. :: Pharmacological Research. 2015 ; 巻 99. pp. 52-62.
@article{e5a408ff12a74053a0d4e78a068f151e,
title = "The exacerbating roles of CCAAT/enhancer-binding protein homologous protein (CHOP) in the development of bleomycin-induced pulmonary fibrosis and the preventive effects of tauroursodeoxycholic acid (TUDCA) against pulmonary fibrosis in mice",
abstract = "The purpose of this study was to evaluate the role of CCAAT/enhancer-binding protein homologous protein (CHOP), an important transcription factor that regulates the inflammatory reaction during the endoplasmic reticulum (ER) stress response, in the development of pulmonary fibrosis induced by bleomycin (BLM) in mice. An intratracheal injection of BLM transiently increased the expression of CHOP mRNA and protein in an early phase (days 1 and 3) in mice lungs. BLM-induced pulmonary fibrosis was significantly attenuated in Chop gene deficient (Chop KO) mice, compared with wild-type (WT) mice. Furthermore, the inflammatory reactions evaluated by protein concentration, the total number of leucocytes and neutrophils in the bronchoalveolar lavage fluid (BALF), the mRNA expression of interleukin 1b and caspase 11, and the apoptotic cell death were suppressed in Chop KO mice compared with those in WT mice. In addition, administration of tauroursodeoxycholic acid (TUDCA), a pharmacological agent that can inhibit CHOP expression, inhibited the BLM-induced pulmonary fibrosis and inflammation, and the increase in Chop mRNA expression in WT mice in a dose-dependent manner. These results suggest that the ER stress-induced transcription factor, CHOP, at least in part, plays an important role in the development of BLM-induced pulmonary fibrosis in mice, and that the inhibition of CHOP expression by a pharmacological agent, such as TUDCA, may be a promising strategy for the prevention of pulmonary fibrosis.",
keywords = "Bleomycin, CHOP, Ddit3, Endoplasmic reticulum stress, Pulmonary fibrosis, Tauroursodeoxycholic acid",
author = "Yuta Tanaka and Yoichi Ishitsuka and Marina Hayasaka and Yusei Yamada and Keishi Miyata and Motoyoshi Endo and Yuki Kondo and Hiroshi Moriuchi and Mitsuru Irikura and Tanaka, {Ken Ichiro} and Tohru Mizushima and Yuichi Oike and Tetsumi Irie",
year = "2015",
month = "6",
day = "11",
doi = "10.1016/j.phrs.2015.05.004",
language = "English",
volume = "99",
pages = "52--62",
journal = "Pharmacological Research",
issn = "1043-6618",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - The exacerbating roles of CCAAT/enhancer-binding protein homologous protein (CHOP) in the development of bleomycin-induced pulmonary fibrosis and the preventive effects of tauroursodeoxycholic acid (TUDCA) against pulmonary fibrosis in mice

AU - Tanaka, Yuta

AU - Ishitsuka, Yoichi

AU - Hayasaka, Marina

AU - Yamada, Yusei

AU - Miyata, Keishi

AU - Endo, Motoyoshi

AU - Kondo, Yuki

AU - Moriuchi, Hiroshi

AU - Irikura, Mitsuru

AU - Tanaka, Ken Ichiro

AU - Mizushima, Tohru

AU - Oike, Yuichi

AU - Irie, Tetsumi

PY - 2015/6/11

Y1 - 2015/6/11

N2 - The purpose of this study was to evaluate the role of CCAAT/enhancer-binding protein homologous protein (CHOP), an important transcription factor that regulates the inflammatory reaction during the endoplasmic reticulum (ER) stress response, in the development of pulmonary fibrosis induced by bleomycin (BLM) in mice. An intratracheal injection of BLM transiently increased the expression of CHOP mRNA and protein in an early phase (days 1 and 3) in mice lungs. BLM-induced pulmonary fibrosis was significantly attenuated in Chop gene deficient (Chop KO) mice, compared with wild-type (WT) mice. Furthermore, the inflammatory reactions evaluated by protein concentration, the total number of leucocytes and neutrophils in the bronchoalveolar lavage fluid (BALF), the mRNA expression of interleukin 1b and caspase 11, and the apoptotic cell death were suppressed in Chop KO mice compared with those in WT mice. In addition, administration of tauroursodeoxycholic acid (TUDCA), a pharmacological agent that can inhibit CHOP expression, inhibited the BLM-induced pulmonary fibrosis and inflammation, and the increase in Chop mRNA expression in WT mice in a dose-dependent manner. These results suggest that the ER stress-induced transcription factor, CHOP, at least in part, plays an important role in the development of BLM-induced pulmonary fibrosis in mice, and that the inhibition of CHOP expression by a pharmacological agent, such as TUDCA, may be a promising strategy for the prevention of pulmonary fibrosis.

AB - The purpose of this study was to evaluate the role of CCAAT/enhancer-binding protein homologous protein (CHOP), an important transcription factor that regulates the inflammatory reaction during the endoplasmic reticulum (ER) stress response, in the development of pulmonary fibrosis induced by bleomycin (BLM) in mice. An intratracheal injection of BLM transiently increased the expression of CHOP mRNA and protein in an early phase (days 1 and 3) in mice lungs. BLM-induced pulmonary fibrosis was significantly attenuated in Chop gene deficient (Chop KO) mice, compared with wild-type (WT) mice. Furthermore, the inflammatory reactions evaluated by protein concentration, the total number of leucocytes and neutrophils in the bronchoalveolar lavage fluid (BALF), the mRNA expression of interleukin 1b and caspase 11, and the apoptotic cell death were suppressed in Chop KO mice compared with those in WT mice. In addition, administration of tauroursodeoxycholic acid (TUDCA), a pharmacological agent that can inhibit CHOP expression, inhibited the BLM-induced pulmonary fibrosis and inflammation, and the increase in Chop mRNA expression in WT mice in a dose-dependent manner. These results suggest that the ER stress-induced transcription factor, CHOP, at least in part, plays an important role in the development of BLM-induced pulmonary fibrosis in mice, and that the inhibition of CHOP expression by a pharmacological agent, such as TUDCA, may be a promising strategy for the prevention of pulmonary fibrosis.

KW - Bleomycin

KW - CHOP

KW - Ddit3

KW - Endoplasmic reticulum stress

KW - Pulmonary fibrosis

KW - Tauroursodeoxycholic acid

UR - http://www.scopus.com/inward/record.url?scp=84930948378&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930948378&partnerID=8YFLogxK

U2 - 10.1016/j.phrs.2015.05.004

DO - 10.1016/j.phrs.2015.05.004

M3 - Article

C2 - 26005208

AN - SCOPUS:84930948378

VL - 99

SP - 52

EP - 62

JO - Pharmacological Research

JF - Pharmacological Research

SN - 1043-6618

ER -